Cardinal Health, Inc.
CAH
Classement en actions
#404
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Prix de l'action
$257.03
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$59.52B
Changement (1 jour)
1.57%
Changement (1 an)
61.98%
Pays
US
Échange Cardinal Health, Inc. (CAH)
Catégorie
Healthcare
Ratio P/E pour Cardinal Health, Inc. (CAH)
Ratio P/E au October 2026 TTM : 34.08
Selon les derniers rapports financiers et le cours de l'action de Cardinal Health, Inc., le ratio P/E actuel (TTM) est de 34.08. À la fin de l’année 2024, le P/E de l’entreprise était de 28.11.
Historique du ratio P/E pour Cardinal Health, Inc. de 2000 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 34.08 | 31.37% |
| 2025 | 25.94 | -7.74% |
| 2024 | 28.11 | -62.42% |
| 2023 | 74.80 | -581.09% |
| 2022 | -15.55 | -156.98% |
| 2021 | 27.28 | -758.91% |
| 2020 | -4.14 | -139.56% |
| 2019 | 10.47 | -82.47% |
| 2018 | 59.70 | 211.31% |
| 2017 | 19.18 | 7.28% |
| 2016 | 17.88 | -21.79% |
| 2015 | 22.86 | 14.00% |
| 2014 | 20.05 | -58.73% |
| 2013 | 48.59 | 258.45% |
| 2012 | 13.55 | -17.90% |
| 2011 | 16.51 | -12.08% |
| 2010 | 18.78 | 175.63% |
| 2009 | 6.81 | -33.21% |
| 2008 | 10.20 | -1.65% |
| 2007 | 10.37 | -46.68% |
| 2006 | 19.45 | 14.79% |
| 2005 | 16.95 | 16.93% |
| 2004 | 14.49 | -1.16% |
| 2003 | 14.66 | -15.53% |
| 2002 | 17.36 | -33.44% |
| 2001 | 26.08 | 12.25% |
| 2000 | 23.23 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 26.02 | -23.64% |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| 45.62 | 33.86% |
AU
|
|
| 24.73 | -27.43% |
US
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.